WHI risks: Any relevance to menopause management?

Maturitas

Volumn 57, Issue 1, 2007, Pages 6-10

  Burger, Henry G ^a  

^a Jean Hailes Foundation for Women's Health   (Australia)

Author keywords

Breast cancer; Cardiovascular disease; Dementia; Hormone therapy; Venous thromboembolism

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEDROXYPROGESTERONE ACETATE; PLACEBO;

AGE DISTRIBUTION; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; BODY MASS; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DEEP VEIN THROMBOSIS; DRUG SAFETY; HEART PROTECTION; HORMONAL THERAPY; HUMAN; LONG TERM CARE; LUNG EMBOLISM; MENOPAUSAL SYNDROME; MONOTHERAPY; NONHUMAN; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; POSTMENOPAUSE; PRESCRIPTION; RISK FACTOR; SMOKING; STROKE; SYMPTOM; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

AGED; ALZHEIMER DISEASE; BODY MASS INDEX; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; DRUG ADMINISTRATION SCHEDULE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OBESITY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; RISK; RISK FACTORS; SMOKING; VENOUS THROMBOSIS;

EID: 34247123119     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.02.002     Document Type: Article

References (18)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in health postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
2. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291 (2004) 1701-1712
3. Grodstein F., Stampfer M.J., Manson J.E., et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335 (1996) 453-461
4. Williams J.K., Anthony M.S., and Honoré E.K. Regression of atherosclerosis in female monkeys. Arterioscler Thomb Vasc Biol 15 (1995) 827-836
5. Manson J.E., Hsia J., Johnson K.C., et al. For the Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 (2003) 523-534
6. Naftolin F., Taylor H.S., Karas R.H., et al. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 81 (2004) 1498-1501
7. Hsia J., Langer R.D., Manson J.E., et al. Conjugated equine estrogens and coronary heart disease: The Women's Health Initiative. Arch Intern Med 166 (2006) 357-365
8. Lobo R.A. Evaluation of cardiovascular event rates with hormone therapy in healthy early postmenopausal women. Arch Intern Med 164 (2004) 482-484
9. Chlebowski R.T., Hendrix S.L., Langer R.D., et al. For the WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 289 (2003) 3243-3253
10. Anderson G.L., Chlebowski R.T., Rossouw J.E., et al. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 55 (2006) 103-115
11. Kuhl H. Is the elevated breast cancer risk observed in the WHI study an artefact?. Climacteric 7 (2004) 319-323
12. Burger H.G. Hormone therapy in the WHI era. ANZCOG 46 (2006) 84-91
13. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer, hormone replacement therapy: collaborative reanalysis of data from 51 epidemiologic studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350 (1997) 1047-1059 [erratum in: Lancet 1997;350:1484]
14. Chen W.Y., Manson J.E., Hankinson S.E., et al. Unopposed estrogen therapy and the risk of invasive breast cancer. Arch Intern Med 166 (2006) 1027-1032
15. Lyytinen H., Pukkala E., and Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 180 (2006) 1354-1360
16. Curb J.D., Prentice R.L., Bray P.F., et al. Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med 166 (2006) 722-780
17. Shumaker S.A., Legault C., Thal L., et al. For the WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
18. Zandi P.P., Carlson M.C., Plassman B.L., et al. For the Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288 (2002) 2123-2129